Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
MAbs ; 15(1): 2205540, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37243580

RESUMO

Three critical aspects that define high concentration antibody products (HCAPs) are as follows: 1) formulation composition, 2) dosage form, and 3) primary packaging configuration. HCAPs have become successful in the therapeutic sector due to their unique advantage of allowing subcutaneous self-administration. Technical challenges, such as physical and chemical instability, viscosity, delivery volume limitations, and product immunogenicity, can hinder successful development and commercialization of HCAPs. Such challenges can be overcome by robust formulation and process development strategies, as well as rational selection of excipients and packaging components. We compiled and analyzed data from US Food and Drug Administration-approved and marketed HCAPs that are ≥100 mg/mL to identify trends in formulation composition and quality target product profile. This review presents our findings and discusses novel formulation and processing technologies that enable the development of improved HCAPs at ≥200 mg/mL. The observed trends can be used as a guide for further advancements in the development of HCAPs as more complex antibody-based modalities enter biologics product development.


Assuntos
Embalagem de Medicamentos , Excipientes , Preparações Farmacêuticas , Viscosidade
2.
Biochim Biophys Acta ; 1617(1-2): 31-8, 2003 Oct 31.
Artigo em Inglês | MEDLINE | ID: mdl-14637017

RESUMO

Factor VIII (FVIII), a plasma glycoprotein, is an essential cofactor in the blood coagulation cascade. It is a multidomain protein, known to bind to phosphatidylserine (PS)-containing membranes. Based on X-ray and electron crystallography data, binding of FVIII to PS-containing membranes has been proposed to occur only via the C2 domain. Based on these models, the molecular topology of membrane-bound FVIII can be envisioned as one in which only a small fraction of the protein interacts with the membrane, whereas the majority of the molecule is exposed to an aqueous milieu. We have investigated the topology of the membrane-bound FVIII using biophysical and biochemical techniques. Circular dichroism (CD) and fluorescence studies indicate no significant changes in the secondary and tertiary structure of FVIII associated with the membranes. Acrylamide quenching studies show that the protein is predominantly present on the surface of the membrane, exposed to the aqueous milieu. The light scattering and electron microscopy studies indicate the absence of vesicle aggregation and fusion. Binding studies with antibodies directed against specific epitopes in the A1, A2 and C2 domains suggest that FVIII binds to the membrane primarily via C2 domain including the specific phospholipid binding epitope (2303-2332) and may involve subtle conformational changes in this epitope region.


Assuntos
Dimiristoilfosfatidilcolina/química , Fator VIII/química , Bicamadas Lipídicas/química , Lipossomos/química , Fosfatidilserinas/química , Acrilamida/química , Anticorpos/química , Anticorpos/imunologia , Sítios de Ligação , Cálcio/química , Fator VIII/imunologia , Fusão de Membrana , Ligação Proteica , Conformação Proteica , Estrutura Secundária de Proteína , Estrutura Terciária de Proteína
3.
Nat Struct Mol Biol ; 22(12): 953-8, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26595420

RESUMO

Immunoglobulin G4 antibodies exhibit unusual properties with important biological consequences. We report the structure of the human full-length IgG4 S228P anti-PD1 antibody pembrolizumab, solved to 2.3-Å resolution. Pembrolizumab is a compact molecule, consistent with the presence of a short hinge region. The Fc domain is glycosylated at the CH2 domain on both chains, but one CH2 domain is rotated 120° with respect to the conformation observed in all reported structures to date, and its glycan chain faces the solvent. We speculate that this new conformation is driven by the shorter hinge. The structure suggests a role for the S228P mutation in preventing the IgG4 arm exchange. In addition, this unusual Fc conformation suggests possible structural diversity between IgG subclasses and shows that use of isolated antibody fragments could mask potentially important interactions, owing to molecular flexibility.


Assuntos
Anticorpos Monoclonais Humanizados/química , Antineoplásicos/química , Imunoglobulina G/química , Receptor de Morte Celular Programada 1/imunologia , Cristalografia por Raios X , Humanos , Conformação Proteica , Estrutura Terciária de Proteína
4.
J Pharm Sci ; 93(10): 2549-57, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15349964

RESUMO

Heavy metals have been implicated in the aggregation of proteins and the pathophysiology of several neurodegenerative diseases. Herein, we describe the interaction of recombinant human factor VIII (rhFVIII) with Al(+3), Tb(+3), Co(+2), and Fe(+3) using a combination of intrinsic fluorescence, circular dichroism, and high-resolution fourth-derivative absorbance analysis. rhFVIII in solution was titrated with the metal cations and the properties of the resulting complexes were examined. rhFVIII has a tendency to aggregate and inactivate slowly over time under physiological conditions, but this aggregation process is greatly accelerated in the presence of metals with Al(+3) being the most efficient. This leads to a complete loss of activity of the protein. Al(+3)-induced conformational changes in the protein were small but detectable with limited changes seen in secondary and tertiary structure. Because rhFVIII is a multidomain protein with subunits linked through divalent metal cations, the small intramolecular changes seen may be attributed to rearrangements of the subunits to an aggregation-competent conformer that is very similar to that of the native form.


Assuntos
Cátions/química , Fator VIII/química , Metais/química , Alumínio/química , Dicroísmo Circular , Cobalto/química , Estabilidade de Medicamentos , Humanos , Ferro/química , Luz , Soluções Farmacêuticas/química , Conformação Proteica , Proteínas Recombinantes/química , Espalhamento de Radiação , Espectrometria de Fluorescência , Espectrofotometria Ultravioleta , Relação Estrutura-Atividade , Temperatura , Térbio/química
5.
J Pharm Sci ; 101(3): 1120-35, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22147527

RESUMO

A systematic approach is presented to characterize and stabilize the higher order structural integrity of an immunoglobulin G (IgG1) monoclonal antibody (mAb) formulated at both low concentrations and as a highly concentrated solution. The conformational and colloidal stabilities of a recombinant humanized IgG1κ mAb at both 1 and 100 mg/mL were investigated as a function of solution temperature (10°C-87.5°C) and pH (3-8). Protein secondary structure was characterized using circular dichroism, whereas intrinsic (tryptophan) and extrinsic (8-anilino-1-naphthalenesulfonic acid) fluorescence spectroscopy measurements were used to evaluate the tertiary structure of the protein. Light scattering analysis was employed to monitor mAb aggregation behavior as a function of temperature and solution pH. These biophysical data sets were analyzed and summarized using a previously described empirical phase diagrams (EPDs) approach. The different phases observed in the EPD were correlated with the individual physical states of the IgG1 in solution (aggregated, native, unfolded, etc.). The temperature-dependent conformational stability profile of the mAb, at both 1 and 100 mg/mL, generally followed the order pH 6 ≥ pH 7 ≥ pH 8 > pH 5 > pH 4 ≥ pH 3. Analysis of the EPD apparent phase boundaries identified solution conditions of pH 4.5 near 60°C for the development of an excipient screening assay. A supplemented generally regarded as safe excipient library was screened using an aggregation assay (optical density at 350 nm) at low mAb concentrations (4 mg/mL) and potential stabilizers were identified. The ability of these excipients to prevent conformational alterations in high concentration mAb solutions (100 mg/mL) was determined by monitoring tertiary structure changes using an intrinsic fluorescence method. The results suggest that substantial increases in the onset temperature of thermal transitions (>5°C) are obtained in the presence of (a) 20% dextrose, (b) 20% sorbitol, and (c) 5% dextrose + 10% sorbitol. Similar stabilization effects were obtained at an intermediate (50 mg/mL) as well as low mAb concentrations (1 mg/mL).


Assuntos
Anticorpos Monoclonais/química , Excipientes/química , Imunoglobulina G/química , Dicroísmo Circular , Humanos , Concentração de Íons de Hidrogênio , Estabilidade Proteica , Estrutura Secundária de Proteína , Proteínas Recombinantes/química , Espectrometria de Fluorescência , Temperatura
6.
Arch Biochem Biophys ; 447(1): 34-45, 2006 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-16487475

RESUMO

Hsc70 and gp96 are two heat shock proteins with molecular chaperone and immune-related activities. The dynamic conformational properties of heat shock proteins appear to play a critical role in their biological activities. In this study, we investigated the effects of pH and temperature on the conformational states of Hsc70 and gp96. The quaternary, tertiary, and secondary structures of both proteins are evaluated by a variety of spectroscopic techniques, including far-UV circular dichroism, Trp fluorescence, ANS fluorescence, and derivative UV absorption spectroscopy. The results are summarized and compared employing an empirical phase diagram approach. Very similar behaviors are seen for both proteins despite their differences in sequence and tertiary structure. Both proteins show substantial conformational lability in responses to the pH and temperature changes of their environment. This study suggests a natural selection for related functional properties through common conformational dynamics rather than immediate structural homology.


Assuntos
Antígenos de Neoplasias/análise , Antígenos de Neoplasias/química , Proteínas de Choque Térmico HSC70/análise , Proteínas de Choque Térmico HSC70/química , Sequência de Aminoácidos , Concentração de Íons de Hidrogênio , Chaperonas Moleculares/análise , Chaperonas Moleculares/química , Dados de Sequência Molecular , Conformação Proteica , Relação Estrutura-Atividade , Temperatura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA